These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3870597)

  • 1. Spontaneous ascites filtration and reinfusion (SAFR): self-care treatment for patients with intractable ascites.
    Landini S; Coli U; Fracasso A; Morachiello P; Righetto F; Scanferla F; Bazzato G
    Life Support Syst; 1985; 3 Suppl 1():375-9. PubMed ID: 3870597
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous ascites filtration and reinfusion (SAFR) in cirrhotic patients.
    Landini S; Coli U; Fracasso A; Morachiello P; Righetto F; Scanferla F; Genchi R; Bazzato G
    Int J Artif Organs; 1985 Sep; 8(5):277-80. PubMed ID: 4086118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous ascites filtration and reinfusion (SAFR) as ambulatory chronic treatment for hepatorenal syndrome.
    Landini S; Coli U; Fracasso A; Morachiello P; Righetto F; Scanferla F; Gallenda F; Bazzato G
    Trans Am Soc Artif Intern Organs; 1985; 31():439-43. PubMed ID: 3837486
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous dialytic ultrafiltration with intraperitoneal reinfusion of the concentrate in 15 cirrhotic patients with intractable ascites.
    Cadranel JF; Grippon P; Gargot D; Lunel F; Bernard B; Valla D; Opolon P
    Int J Artif Organs; 1992 Mar; 15(3):168-71. PubMed ID: 1521902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients].
    Takahashi Y; Imai H; Ikawa A; Yasuda K; Kawai M; Yamamori T; Furuichi N; Misawa K; Ohashi H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1820-4. PubMed ID: 10560403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reinfusion of ascitic fluid in the treatment of ascites in patients with liver cirrhosis].
    Zhuravlev VA; Sukhorukov VP; Shishkin BA
    Sov Med; 1983; (2):95-7. PubMed ID: 6857357
    [No Abstract]   [Full Text] [Related]  

  • 7. [The development of FSCLZLY--an ascites-ultrafiltration instrument].
    Liu CY; Hu DR; Peng XJ; Tian HY; Gong LJ; Chen TB
    Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Mar; 26(2):131-2, 143. PubMed ID: 16104180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for ascites concentration and reinfusion.
    Borzio M; Romagnoni M; Sorgato G; Bruno S; Borzio F; Tarasco V; Tetta C; Modignani RL
    Dig Dis Sci; 1995 May; 40(5):1054-9. PubMed ID: 7729263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialytic ascitic ultrafiltration in refractory ascites.
    Hwang ER; Sherman RA; Mehta S; Walker JA; Goodling KA; Hariprasad MK; Eisinger RP
    Am J Gastroenterol; 1982 Sep; 77(9):652-4. PubMed ID: 7114029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of intractable ascites using continued puncture re-infusion. The Rhodiascit system].
    Van Waes L; Demeulenaere L
    Tijdschr Gastroenterol; 1973; 16(6):396-409. PubMed ID: 4782125
    [No Abstract]   [Full Text] [Related]  

  • 11. Intractable ascites: treatment by continuous autogenous ascitic infusion.
    Hacker LC; Reinhardt GF; Brettschneider L; Stanley MM
    Rev Surg; 1974; 31(6):449-53. PubMed ID: 4432042
    [No Abstract]   [Full Text] [Related]  

  • 12. [A simple method for the reinfusion of ascitic fluid in hemodialysis patients].
    Kron J; Schöllner P; Wenkel R
    Z Urol Nephrol; 1981 Jul; 74(7):497-500. PubMed ID: 7303972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of ascites with reinfusion of ascitic fluid concentrate].
    Narwan H; Demes M; Kovac A; Danninger F
    Bratisl Lek Listy; 2000; 101(5):306-9. PubMed ID: 11039198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of refractory ascites with ultrafiltration and peritoneal reinfusion in a patient with right ventricular dilated cardiomyopathy.
    Lammert F; Nguyen HN; Strohbach P; Wylenzek M; Kierdorf HP; Matern S
    Dig Dis Sci; 2001 Mar; 46(3):499-503. PubMed ID: 11318522
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous dialytic ultrafiltration and intraperitoneal reinfusion in cirrhotic patients with intractable ascites. Preliminary results of a comparative study versus large paracentesis.
    Cadranel JF; Grippon P; Gargot D; Lunel F; Bernard B; Valla D; Opolon R
    J Hepatol; 1992 May; 15(1-2):271-2. PubMed ID: 1506653
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients.
    Lévy VG; Opolon P; Pauleau N; Caroli J
    Postgrad Med J; 1975 Aug; 51(598):564-6. PubMed ID: 1234342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixty-two cases of intractable ascites due to cirrhosis treated by the modified Wulingsan power plus abdominal reinfusion of the concentrated ascites after ultrafiltration.
    Zhao HP; Zhang ZR; Ding BH; Guo SM; Zhao YZ; Dong SN
    J Tradit Chin Med; 2009 Jun; 29(2):115-20. PubMed ID: 19663098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of dialytic ultrafiltration and peritoneal reinfusion in the management of diuretic resistant ascites.
    Raju SF; Achord JL
    Am J Gastroenterol; 1984 Apr; 79(4):308-12. PubMed ID: 6711532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate.
    Parbhoo SP; Ajdukiewicz A; Sherlock S
    Gut; 1973 May; 14(5):421-2. PubMed ID: 4716516
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
    Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
    BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.